Source comparison
Melanotan 1 vs 2: Safety and Side Effect Profiles
The melanotan 1 vs 2 comparison strongly favors melanotan 1 on safety documentation. As the active ingredient in Scenesse (EU-approved by the European Medicines Agency), melanotan 1/afamelanotide has undergone formal clinical trials, safety reviews, and post-m
This comparison does not assign a generated winner or score.
- The melanotan 1 vs 2 comparison strongly favors melanotan 1 on safety documentation. As the active ingredient in Scenesse (EU-approved by the European Medicines Agency), melanotan 1/afamelanotide has undergone formal clinical trials, safety reviews, and post-marketing surveillance — producing the most comprehensive safety dataset of any melanocortin tanning peptide. Common effects are limited to mild injection site reactions and occasional nausea.
- Melanotan 2 has a less characterized safety profile because it has not undergone regulatory review. Community-documented effects include: nausea (moderate during loading, usually transient), facial flushing, pronounced darkening of existing moles and freckles (requiring mole monitoring), libido enhancement, mild appetite suppression, and rare reports of dizziness. Most effects are transient and dose-dependent. In the melanotan 1 vs 2 comparison, researchers prioritizing the most conservative safety approach choose melanotan 1.